You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dosimetry

Showing 26 - 50 of 1,002
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Carcinoma, Metastatic Thyroid Carcinoma Trial in New York (PET/CT Scan, Iodine-124)

Recruiting
  • Thyroid Carcinoma
  • Metastatic Thyroid Carcinoma
  • New York, New York
  • +1 more
Aug 1, 2022

Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)

Not yet recruiting
  • Prostate Cancer
  • Lutetium Lu 177 JH020002 Injection
  • (no location specified)
Nov 14, 2023

Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

Recruiting
  • Adrenocortical Carcinoma
  • 68Ga-R8760 injection at pre-defined dose levels
  • 68GA-R8760 injection
  • Ann Arbor, Michigan
    University of Michigan Nuclear Medicine
Aug 11, 2023

Transcranial Direct Current Stimulation Trial in Tempe, Gainesville (tDCS, Sham)

Completed
  • Transcranial Direct Current Stimulation
  • tDCS
  • Sham
  • Tempe, Arizona
  • +1 more
Jun 24, 2022

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Healthy Subjects (HS) Trial in Huangpu (DaTSCAN™ Ioflupane (123I) Injection)

Completed
  • Healthy Subjects (HS)
  • DaTSCAN™ Ioflupane (123I) Injection
  • Huangpu, Shanghai, China
    Rujin hospital, affiliated to Shanghai Jiaotong University, Scho
Jun 20, 2022

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Completed
  • Huntington Disease
  • [11C]CHDI-00485180-R
  • [11C]CHDI-00485626
  • Leuven, Belgium
    UZ Leuven
May 18, 2022

Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

Active, not recruiting
  • Thyroid Cancer
  • 131 I-iodine (131-I), 124 I-iodine (124-I)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Prostate Cancer, mCRPC Trial in Seoul (Lu-177-DGUL, Ga-68-NGUL)

Recruiting
  • Prostate Cancer
  • mCRPC
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2022

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Optimisation of dental implant sites protection from irradiation
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Aug 2, 2022

Diabetic Kidney Disease Trial in San Diego (Tc-99m-Tilmanocept)

Recruiting
  • Diabetic Kidney Disease
  • Tc-99m-Tilmanocept
  • San Diego, California
    UC San Diego Medical Center
Feb 16, 2022

Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)

Not yet recruiting
  • Prostate Cancer
  • Phase I:[177Lu]Lu-XT033 Injection
  • Phase II:[177Lu]Lu-XT033 Injection
  • Beijing, Beijing, China
  • +1 more
Oct 7, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 16, 2023

Metastatic Differentiated Thyroid Cancer Trial in Negrar, Milan (Radioiodine optimized therapy)

Recruiting
  • Metastatic Differentiated Thyroid Cancer
  • Radioiodine optimized therapy
  • Negrar, Verona, Italy
  • +1 more
Mar 18, 2022

Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Jul 26, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • Toronto, Ontario, Canada
    University Health Network - Princess Margaret Cancer Centre
Aug 16, 2022

Acquisition Time, Respiratory Gating and New Qclear

Completed
  • Carcinoma, Hepatocellular
  • PET/CT Exam
  • Bordeaux, France
    CHU Bordeaux
Mar 29, 2022

Differentiated Thyroid Cancer Trial in Leiden (rhTSH-stimulated I-124 dosimetry, Intra-therapeutic I-131 dosimetry)

Recruiting
  • Differentiated Thyroid Cancer
  • rhTSH-stimulated I-124 dosimetry
  • Intra-therapeutic I-131 dosimetry
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Apr 8, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Hemoptysis, Malignant Tumor, Lung Cancer Trial (Technicium 99 MAA infusion)

Withdrawn
  • Hemoptysis
  • +2 more
  • Technicium 99 MAA infusion
  • (no location specified)
Aug 15, 2022

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar)

Completed
  • Coronary Artery Disease
  • Ga-68 Galmydar
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 5, 2022

Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • (no location specified)
Jul 28, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023